ArticleScientific reports2025

Oral colon-targeted responsive chitosan/pectin-based nanoparticles propels the application of tofacitinib in colitis therapy.

Chunfei Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.